Publication: 3924

Publication: 3924

Alliance A021804: A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide versus Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 41 (suppl 16) TPS4191

Meeting Instance:: ASCO 2023
Year:: 2023
Type:: Abstract
Sub type:: Poster Discussion
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG)

Corr. Author:
Authors:: Jaydira del Rivero Kimberly J. Perez Susan Geyer Maged Khalil Aishwarya Vijendrn Andrea Kordaris-Corkill Ardaman Shergill Kristen Spencer Heloisa Soares Charles Lopez Andre Nixon Amylou Dueck Jeffrey Meyerhardt Eileen M. O'Reill

Networks:: LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-UT003, MCRC, MD001, OR013

Study: Alliance-A021804
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: